Compare FNWB & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNWB | ZTEK |
|---|---|---|
| Founded | 1923 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 68.8M |
| IPO Year | 2012 | 2022 |
| Metric | FNWB | ZTEK |
|---|---|---|
| Price | $8.99 | $0.55 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | 34.5K | ★ 66.6K |
| Earning Date | 04-23-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.80% | N/A |
| EPS Growth | ★ 36.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $176,000.00 | N/A |
| Revenue This Year | $19.24 | N/A |
| Revenue Next Year | $8.90 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.05 | $0.50 |
| 52 Week High | $10.98 | $1.84 |
| Indicator | FNWB | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 38.71 |
| Support Level | $7.56 | $0.55 |
| Resistance Level | $9.00 | $0.75 |
| Average True Range (ATR) | 0.29 | 0.04 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 67.28 | 33.33 |
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.